Summary Slide.png (77.29 kB)

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

Download (77.29 kB)
figure
posted on 20.04.2020 by Timothy Smith, John H Krege, Suchitrita S Rathmann, Sherie A Dowsett, Ann Hake, Emel SM Nery, Brandy R Matthews, Erin G Doty

The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

Funding

CoLucid Pharmaceuticals, a subsidiary of Eli Lilly and Company.

History

Exports

Logo branding

Exports